-+ 0.00%
-+ 0.00%
-+ 0.00%

Atara Biotherapeutics Awaits FDA Decision on Tab-cel® BLA with PDUFA Target Date Set for January 10, 2026, Potential $40 Million Milestone from Pierre Fabre Laboratories

Reuters·08/11/2025 20:09:36

Please log in to view news